ir.bgp-co.com
هولوگرام بعد گسترپیام
۱ برچسب ضد تقلب مدل تی ای. ۲ برچسب ضد تقلب مدل باطل VOID. ۳ برچسب ضد تقلب مدل چنج کالر. ۴ برچسب ضد تقلب مدل تی ای اف. ۵ برچسب ضد تقلب مدل تی ای اس. ۶ برچسب ضد تقلب مدل فرانگیبل. ۷ برچسب ضد تقلب مدل OCRE. ۸ برچسب ضد تقلب مدل اسکرچ. ۹ برچسب ضد تقلب مدل تی ای تی. ۱ برچسب ضد تقلب مدل تی ای. برچسب ضد تقلب مدل تی ای : قابلیت این مدل به صورتی است که پس از چسباندن بر روی سطح محصول، اقدام برای . ۲ برچسب ضد تقلب مدل باطل VOID. ۳ برچسب ضد تقلب مدل چنج کالر. ۴ برچسب ضد تقلب مدل تی ای اف. ۵ برچسب ضد تقلب مدل تی ای اس.
ir.biglotscorporate.com
BigLots Corporate - Stock Quote
Stock Quote Stock Chart. 160; 0.38. Data as of 08/07/15Â 4:02 pm ET. Minimum 20 minute delay. Data provided by Nasdaq. Minimum 15 minutes delayed. Minimum 20 minutes delayed.
ir.bilkent.edu.tr
International Relations | Bilkent University
Talks and Public Lectures. Global and International Affairs Program (GIA). IR Courses on the Web. IR Postgraduate Students Talking. What our students say. New Book Published by Dimitri Tsarouhas. The Dynamics of Turkish Defense Industrialization. Date&Time: 15.12.2017, Friday, 12.30. Taking Tounge: Espionage and Intelligence in Sixteenth Century Mediterranean. Dr Emrah Safa Gürkan. Date&Time: 29.11.2017, Wednesday, 12.40. POLS TALKS: Contested Identities in History: The Case of Turkey and Europe by Assoc...
ir.billion.com
Billion-Iran
Billion Distributor in Iran :. Sales Contact : sales@keyhantelecom.com. Technical Support: support@keyhantelecom.com. For any inquiry about our product or selling information, you are welcome to fill out the Online Order Form. To initiate business partnership with Billion, please fill out the Recruiting Partners Application Form. For marketing services, please email us at marketing@billion.com. For public relations, please contact us at press@billion.com.
ir.bimeks.com.tr
Bimeks
214;zel Durum Açıklamaları. 1- Bimeks yaza 3 açılışla merhaba dedi. 2- Bimeks SSH, Balon Futbolu Turnuvası şampiyonu oldu. 3- Bimeks hafta sonları Samsunsporlu. 4- Bimeks Düzce mağazası Krempark AVMde. 5- Boğaziçinde müzik ile teknoloji iç içe. 6- Bimeks Yıl Değerlendirme Toplantısı: Daha Yolun Başındayız. 7- Capital, Türkiyenin kâr haritasını çıkardı. 8- Arif Bayraktar: Deneyim duygusu hâlâ çok kıymetli. 9- Bimeksten ilk çeyrekte %30 ciro büyümesi. 10- Dr. Ahmed Akgiray Ekonomiste röportaj verdi. Bimeks...
ir.bindtherapeutics.com
BIND Therapeutics, Inc. - Investor Relations
BIND In the News. We are a clinical-stage nanomedicine platform company developing Accurins™. A new class of targeted and programmable therapeutics developed using our Medicinal Nanoengineering. Platform. Accurins are nanoparticles designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease, enhancing efficacy while minimizing adverse effects on healthy tissues. We are developing our own pipeline. BIND Ther...
ir.binus.ac.id
International Relations BINUS University |
International Relations BINUS University. International Relations BINUS University. International Relations BINUS University. Vision & Mission. Prospective Career of The Graduate. Quality Controlled Examinations (UPM). Luh Nyoman Ratih Wagiswari Kabinawa. Journal of ASEAN Studies. Impact and Media Coverage. Journal of ASEAN Stud. The Journal of ASEAN Studies is pleased to present our new edition: Volume 3, Number 1, published in the first half of 2015. This is the fifth pub. SCG Young Leaders Program.
ir.bioblast-pharma.com
Investors Overview | Bioblast Pharma
Our Platforms and Pipeline. BioBlast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ - "ORPN") committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Founded in 2012, the company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical need for incurable rare diseases. SCA3 POC - 2015 International Ataxia Research Conference. SMA-BBrm02 POC - CureSMA Meeting 2015. TEL AVIV, ...
ir.bioblastpharma.com
Investors Overview | Bioblast Pharma
Thomas I. H. Dubin. Bioblast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ - "ORPN") committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Our therapeutic platforms are based on deep understanding of the disease-causing biological processes, and can potentially offer solutions for several diseases that share the same biological pathology. SCA3 POC - 2015 International Ataxia Research Conference. November 29, 2016. Biobl...
ir.biocept.com
Investor Relations - Biocept Inc.
Annual Reports and Proxies. Aug 11, 2015. Biocept and University of California, Irvine to Study Blood-based Liquid Biopsy Testing in Cancer Patients. Aug 10, 2015. Biocept Reports Second Quarter 2015 Financial Results. View all press releases ». Sep 9, 2015. Biocept presents at the Rodman and Renshaw 17th Annual Global Investment Conference. View all events and presentations ». Contact Biocept, Inc. Biocept, Inc. Headquarters. 5810 Nancy Ridge Drive, Suite 150. San Diego, CA 92121. T: 858.320.8200.
ir.bioneer.co.kr
(주)바이오니아
인사 및 복리 후생. 단신) 2018 MEDLAB 참가. HIV-1 Kit 올해 . 인증획득 기대. 박한오 대표, . POC 분자진단 기술 발표. 탈모방지 기능성화장품 개발 . 진행중.
SOCIAL ENGAGEMENT